AB016. SOH26AB_0294. The use of CT radiomics for predicting the malignant potential of residual retroperitoneal masses post-chemotherapy in metastatic testicular cancer: a systematic review and meta-analysis
Mesentery and Peritoneum · 2026-04 · 10 · AB016-AB016
DOI: 10.21037/map-26-ab016 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Mesentery and Peritoneum, 2026-04. Verfasst von James Kelly und 3 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kelly, J., Calpin, G., Kelly, R., & Quinlan, M. (2026). AB016. SOH26AB_0294. The use of CT radiomics for predicting the malignant potential of residual retroperitoneal masses post-chemotherapy in metastatic testicular cancer: a systematic review and meta-analysis. Mesentery and Peritoneum, 10, AB016-AB016. https://doi.org/10.21037/map-26-ab016
Vancouver
Kelly J, Calpin G, Kelly R, Quinlan M. AB016. SOH26AB_0294. The use of CT radiomics for predicting the malignant potential of residual retroperitoneal masses post-chemotherapy in metastatic testicular cancer: a systematic review and meta-analysis. Mesentery and Peritoneum. 2026;10:AB016-AB016. doi:10.21037/map-26-ab016
BibTeX
@article{Kelly2026,
author = {Kelly, James and Calpin, Gavin and Kelly, Robert and Quinlan, Mark},
title = {AB016. SOH26AB_0294. The use of CT radiomics for predicting the malignant potential of residual retroperitoneal masses post-chemotherapy in metastatic testicular cancer: a systematic review and meta-analysis},
journal = {Mesentery and Peritoneum},
year = {2026},
volume = {10},
pages = {AB016--AB016},
doi = {10.21037/map-26-ab016}
}
EUVIMED